Samuel Backenroth, Chief Financial Officer at Ohr Pharmaceutical Inc (OHRP), bought 1,500 shares at $6.75 ($10K) on 2015-02-06, disclosed to the SEC on 2015-02-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| OHRP | BUY | 2016-06-21 | $7K | — | Filing → |
| OHRP | BUY | 2016-05-24 | $8K | — | Filing → |